Hematology & Anticoagulant Drugs Flashcards

1
Q

Hemophilia - pathophysiology

A

Coagulation factor deficiency –> impaired ability to form clots –> excessive bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hemophilia A involves a deficiency in:

A

factor VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hemophilia B involves a deficiency in:

A

factor IX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What % of hemoglobin is normal in mild hemophilia? In moderate? In severe?

A

mild = 6-49% is normal
moderate = 1-5% is normal
severe <1% is normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications for treating hemophilia A

A

factor VIII concentrate
DDAVP - desmopressin
antibody therapy
gene therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factor VIII Concentrate

A

Dose by % increase in factor desired & body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Desmopressin

A

a synthetic analog of ADH, releases stored factor VIII from endothelium, used for mild hemophilia A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antibody therapy

A

Monoclonal antibody (an antibody that has been cloned from a WBC) works by binding together 2 factors in the clotting cascade (IXa & X) that would normally be where factor VIII would work, prophylactic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gene therapy

A

very expensive, reconstruction / repair of genetic material in patient’s body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment for Hemophilia B

A

Factor IX concentrate - dose by % increase in factor desired & body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Microcytic anemias

A

iron deficiency, anemia of chronic disease, thalassemia, sideroblastic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Normocytic anemias

A

corrected reticulocyte count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Macrocytic anemias

A
  • megaloblastic: folate deficiency, Vit B12 deficiency
  • nonmegaloblastic: liver disease, alcoholism, reticulocytosis, drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Iron

A
  • absorbed in small intestine, stored as ferratin or binds transferrin for distribution
  • goes to bone marrow for use in HgB
  • recycled, very minimal leaves body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Iron deficiency

A
  • due to uptake / demand imbalance
  • results in decreased O2 carrying capacity (fatigue, pallor, tachycardia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Iron supplementation

A
  • PO or parenteral (PO unless unable to absorb / tolerate PO iron)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PO iron side effects

A
  • GI disturbances (nausea, heartburn, bloating); take w/ food & water
  • leading cause of poisoning fatalities in young children
  • treat for 1-2 months or until HgB normalizes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Vit B12

A
  • required for DNA synthesis & cell growth / division
  • catalyzes folic acid to active form
  • requires intrinsic factor (parietal cells of stomach) for absorption
  • storage in liver, slow elimination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

B12 deficiency causes:

A

bone marrow suppression
decreased GI tract mucosa
*neuronal demyelination of the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When are B12 injections preferred?

A

If neurologic deficits (d/t neuronal demyelination of the CNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Adverse effect of B12 supplementation

A

hypokalemia due to increased erythrocyte production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Folic acid

A
  • required for DNA synthesis & cell division / growth
  • must be converted to active form, 2 pathways (1 includes B12)
  • absorbed in small intestine, stored in liver, extensive enterohepatic recirculation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Consequences of folic acid deficiency

A

bone marrow suppression
GI tract mucosa decrease
fetal neural tube defects
can increase colorectal CA & atherosclerosis risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

is folic acid or folinic acid replacement preferred

A

folic acid (the folinic acid active form is more expensive & not any more effective)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Why is B12 given in severe folic acid deficiency?

A

B12 is utilized in converting folic acid to its active form

**folic acid can also be converted to its active form via a different pathway too!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

erythropoietin (EPO) results in:

A

stimulation of RBC production in bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Uses for hematopoietic agents

A
  • anemia due to kidney disease
  • chemo induced anemia (only for palliation)
  • anemia pre-operatively
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

adverse effects of exogenous EPO

A

HTN
CV events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what increases the risk of CV events with exogenous EPO?

A

Hgb>11
or
Hgb increase >1 in 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

formulations of exogenous EPO

A

epoetin alfa
darbepoetin (longer 1/2 life, slower clearance, can admin less frequently)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are leukopoietic growth factors?

A

substances that stimulate WBC proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Uses for leukopoietic growth factors

A
  • patients undergoing myelosuppressive chemo
  • patients undergoing bone marrow transplant
  • sever chronic neutropenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

adverse effects of leukopoietic growth factors?

A

leukocytosis
bone pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

formulations of leukopoietic growth factors

A

G-CSF: filgrastim
GM-CSF: sargramostim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What do thrombopoietin receptor agonists do?

A

stimulate platelet production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Uses for throbopoietin receptor agonists

A
  • idiopathic thrombocytopenic purpura (immune mediated destruction of platelets & impaired platelet production)
  • thrombocytopenia w/ liver disease pre op
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Two main steps in forming a clot

A
  1. platelet plug
  2. fibrin mesh
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

fibrinogen connects activated platelets by binding:

A

GPIIb/IIIa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

platelet activation occurs upon exposure to an agonist such as:

A

ADP
TXA2
thrombin
collagen
platelet activation factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is fibrin?

A

threadlike protein that reinforces the platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Pathways to produce fibrin

A
  1. intrinsic: triggered by collagen contact (injured BV)
  2. extrinsic: triggered by thromboplastin (released by vascular wall trauma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What does antithrombin do?

A

inhibits some of the coagulation factors so clotting doesn’t get out of control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Which factors depend on vitamin K for their synthesis?

A

II, VII, IX, X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

what degrades the fibrin mesh?

A

plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What happens with arteriole thrombosis formation?

A

Lack of adequate blood flow (oxygenation) to distal tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What happens with venous thrombosis formation?

A

Possibility of pieces breaking off (emboli) and traveling to lungs/brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which drugs activate antithrombin?

A

heparin
LMWH (enoxaparin, dalteparin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

How does heparin work?

A

activates antithrombin –>
increased inhibition of some clotting factors (= suppression of thrombin & factor Xa)
–> decreased ability to create fibrin mesh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Which major step in coagulation does heparin inhibit?

A

Fibrin mesh formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

LMWH

A

greater suppression of factor Xa than thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Fondaparinux

A

only suppression of factor Xa, no thrombin suppression –> decreased fibrin formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What type of drug is warfarin?

A

Anticoagulant
Vitamin K antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

How does warfarin work?

A

inhibits VKORC1 (vitK epoxie reductase complex 1)
vitK cannot be converted to active form

factors II, VII, IX, X are decreased = fibrin mesh formation is decreased

54
Q

Which major step in coagulation does warfarin inhibit?

A

fibrin mesh formation

55
Q

How do direct thrombin inhibitors work?

A

Bind & inhibit thrombin
Thus fibrin can’t be formed & factor XIII can’t be activated.

Decreased fibrin mesh formation

56
Q

What major step in coagulation do direct thrombin inhibitors inhbit?

A

Fibrin mesh formation

57
Q

Name a couple direct thrombin inhibitors

A

dapigatran
desirudin
bivalrudin
argatroban

58
Q

How do direct factor Xa inhibitors work?

A

bind & inhibit factor Xa = decreased thrombin production

= decreased fibrin mesh formation

59
Q

What major step in coagulation do direct factor Xa inhibitors inhibit?

A

fibrin mesh formation

60
Q

List a couple direct factor Xa inhibitors

A

rivaroxaban
apixaban

61
Q

What is the primary source of thrombi in veins?

A

fibrin
*thus anti-fibrin drugs are especially helpful for preventing DVTs

62
Q

How is heparin administered?

A

IV or subQ

63
Q

Why do IV infusions of heparin have to be monitored with PTT checks?

A

widely variable protein binding, so effects amongst various patients are unpredictable

64
Q

What is normal PTT

65
Q

What is often the therapeutic goal of heparin infusion?

A

PTT 60-80sec

66
Q

antidote for heparin

67
Q

How does protamine work?

A

binds heparin, inactivating it

68
Q

adverse effects of high dose heparin?

A

hemorrhage
heparin induced thrombocytopenia
hypersensitivity reactions
spinal / epidural hematoma

69
Q

Heparin - therapeutic uses

A
  • situations that require rapid anticoagulation (PE, DVT)
  • open heart surgery or dialysis prevent device coagulation
  • low dose SubQ for DVT prevention
  • treatment of DIC
  • adjunct in acute MI
70
Q

What is HIT (heparin induced thrombocytopenia)?

A

immune response against heparin: antibodies are produced against heparin-platelet complexes

71
Q

What does HIT result in?

A

consumption of platelets (decreased platelets available to clot) = thrombocytopenia

increased platelet activation = increased thromboembolic events

72
Q

What lab values might you expect to change in heparin induced thrombocytopenia?

A

PTT increase
platelet decrease (drastically)

73
Q

Treatment for heparin induced thrombocytopenia?

A

d/c heparin
use alternative anticoagulant

74
Q

Why don’t LMWH require PTT monitoring?

A

decreased protein binding & slower clearance: predictable pharmacokinetics

75
Q

LMWH

A
  • Enoxaparin & dalteparin = more Xa than thrombin inhibition
  • AE = bleeding (less common than w/ heparin)
76
Q

How is warfarin given?

77
Q

Warfarin - mechanism

A
  • Vitamin K antagonist
  • decreases production of factors II, VII, IX & X
  • results in decreased fibrin formation
78
Q

What might occur if another highly protein bound drug is given to your patient on warfarin?

A

Increased free warfarin = overdose
Increased bleeding risk

79
Q

What lab value is monitored during warfarin administration?

80
Q

What is the normal INR value?

81
Q

What is the goal INR in warfarin therapy?

82
Q

Warfarin PK

A

PO, 99% protein bound, free drug crosses membranes, CYP450 metabolism, renal/fecal excretion

83
Q

Why is warfarin not used for acute clotting issues?

A

Doesn’t inhibit the vitK factors that are already synthesized - thus effects take a few days

(just inhibits the formation of future vitK factors)

84
Q

Warfarin - therapeutic uses

A
  • long term prevention of thrombosis: DVT/PE, thromboembolism in prosthetic heart valves, thrombosis in chronic a fib, those at risk of recurrent MI/TIA
85
Q

Adverse effects of warfarin

A

hemorrhage
fetal hemorrhage (contraindicated in pregnancy)
infant hemorrhage (caution in breasfeeding)

86
Q

antidote of warfarin

A

vitamin K (phenytonadione)
FFP
plasma concentrates of factor II, VII, IX, X

87
Q

Dietary guidance for a patient being prescribed warfarin:

A

caution with excessive dietary vitK:
- leafy green veggies
- mayo
- canola oil

88
Q

Warfarin / drug interactions: increase anticoagulant effects

A
  • highly protein bound drugs (displacement of warfarin)
  • CYP450 inhibitors
  • decreased synthesis of clotting factors
  • acetaminophen?
89
Q

Warfarin / drug interactions - promote bleeding

A
  • inhibition of platelet aggregation
  • inhibition of clotting factors
  • generation of GI ulcers
  • heparin, aspirin, many OTC supps
90
Q

Warfarin drug/food interactions - decrease coagulant effects

A
  • CYP450 inducers
  • increased synthesis of clotting factors
  • inhibition of warfarin absorption
  • increased dietary vit K intake
91
Q

Direct thrombin inhibitors

A

dabigatran, desirudin, bivalrudin, argatrobin

92
Q

Mechanism of direct thrombin inhibitors

A
  • binds / inhibits thrombin that is already bound to clots –> decreased conversion of fibrinogen to fibrin, decreased activation of factor XIII
93
Q

End result of direct thrombin inhibitors

A

decreased conversion of soluble to insoluble fibrin

94
Q

Pros of direct thrombin inhibitors

A
  • rapid onset
  • no need to monitor lab values, predictable responses = reliable dosing
  • few drug food interactions
  • lower risk of major bleeding
95
Q

Direct thrombin inhibitors - PK

A
  • PO
  • peak 1-3 hrs (food affects absorption rate)
  • low protein binding
  • renal elimination, no liver metabolism
  • 1/2 life = 13 hrs (norm renal function), 18 hrs (mod renal dysfunction)
96
Q

What is unique about bivalrudin (compared with the other direct thrombin inhibitors)?

A

IV only (continuous infusion)
immediate onset
short duration
eliminated by renal excretion & proteolytic cleavage

97
Q

Therapeutic uses of direct thrombin inhibitors

A
  • A fib
  • tx for DVT / PE
  • prevention of thrombosis
  • knee / hip replacement
98
Q

adverse effects of direct thrombin inhibitors

A

hemorrhage (less than warfarin)
GI disturbances

bivalrudin can cause back pain, hypotension, and headache

99
Q

Do you need to monitor lab values for direct thrombin inhibitors or direct factor Xa inhibitors?

100
Q

Mechanism of Rivaroxaban

A
  • selective binding & inhibition of factor Xa
  • decreased production of thrombin
  • inhibition of fibrin mesh formation
101
Q

Advantages of rivaroxaban

A

rapid onset, fixed dosage, lower bleeding risk, few drug interactions, no lab monitoring required

102
Q

Rivaroxaban - PK

A

PO, peak 2-4 hrs, CYP450, 35% unchanged in urine

103
Q

Rivaroxaban - therapeutic uses

A
  • PE/DVT prevention after ortho procedures
  • stroke prevention w/ a fib
  • DVT/PE prevention
  • tx of DVT/PE
104
Q

adverse effects of rivaroxaban

A

hemorrhage (less than warfarin)
maternal hemorrhage risk + fetal effects (avoid in pregnancy)

105
Q

“Antidote” of rivaroxaban

A
  • can give activated charcoal to avoid further absorption
  • hemorrhage = factor VIIa or factor II (prothrombin)
106
Q

Factor Xa inhibitors

A

apixaban, betrixaban, endoxaban, rivaroxaban

107
Q

How does aspirin decrease clotting?

A

irreversibly inhibits cyclooxygenase = decreased thromboxane A2 (TXA2) formation

(TXA2 agonizes platelet activation & aggregation)

108
Q

What major step in clotting does aspirin inhibit?

A

platelet activation & aggregation

109
Q

what class of medication is aspirin?

A

COX inhibitor

110
Q

Aspirin - PK

A

effects last lifetime of platelet (7-10 days)

111
Q

Aspirin indications & AE

A
  • indications: CVA, TIA, chronic stable angina, stents, acute MI
  • AE: GI bleeding, hemorrhagic stroke
112
Q

How do P2Y12 ADP receptor antagonists work?

A

block P2Y12 ADP receptors on platelet surface –> decreased activation and aggregation

113
Q

What major step in clotting do P2Y12 ADP receptor antagonists inhibit?

A

platelet activation & aggregation

114
Q

List some P2Y12 ADP receptor antagonists

A

clopidogrel (irreversible)
prasugrel (irreversible)
ticagrelor (reversible)

115
Q

PK, use & AE for P2Y12 ADP antagonists

A
  • PK: PO, hepatic met, effects in 2 hrs, 7-10 days = duration
  • use = prevention of stent thrombosis & thrombotic events
  • adverse = same as aspirin (bleeding TTP)
116
Q

How do PAR-1 antagonists work?

A

inhibit PAR1 receptors on platelet surface = decreased platelet activation/aggregation; mediate effects of thrombin

117
Q

What major step in coagulation do PAR1 antagonists inhibit?

A

platelet activation/aggregation

118
Q

Name a PAR1 antagonist

119
Q

PAR 1 PK, uses, AE

A
  • PK: PO, effects in 1 hr, hepatic met, fecal excretion, 8 days = 1/2 life
  • uses = w/ aspirin/clopidogrel in reduction of thrombotic events
  • AE = bleeding
120
Q

How do GP IIb/IIIa receptor antagonists work?

A

block GPIIb/IIIa receptors on platelet surface = inhibit FINAL COMMON STEP in platelet aggregation
(thus making them the MOST effective antiplatelet drug)

121
Q

list some GPIIb/IIIa receptor antagonists

A

abciximab
tirofiban
eptifibatide

122
Q

Which antiplatelet drug is most effective

A

GP IIb/IIIa receptor antagonists
(like abciximab)

123
Q

duration of action of single dose of aspirin

A

7-10 days (lifetime of platelet due to irreversible binding)

124
Q

duration of action of single dose clopidogrel (Plavix)

A

7-10 days (lifetime of platelet due to irreversible binding)

125
Q

Why are GPIIb/IIIa receptor antagonists the most powerful antiplatelet drug?

A

all other platelet activating/aggregating agonists (TXA2, etc.) require the GP IIb/IIIa receptor

126
Q

What do thrombolytic drugs do?

A

break down thrombi that have already formed

127
Q

list some thrombolytics

A

alteplase (tPA)
reteplase
tenecteplase

128
Q

how do thrombolytic drugs work?

A

activate plasmin which breaks down fibrin mesh
also degrades clotting factors

129
Q

route of administration of thrombolytic drugs

130
Q

uses for thrombolytic drugs

A

acute MI, CVA, PE

131
Q

adverse effects of thrombolytic drugs

A

hemorrhage!

132
Q

How to prevent hemorrhage when administering thrombolytic drugs

A
  • minimize patient manipulations
  • avoid invasive procedures (even PIV placement!)
  • avoid subQ/IM injections
  • minimize concurrent use of other blood thinners